Background: Assessment of symptoms should be the primary outcome measure in dyspepsia clinical trials. This requires a reliable, valid and responsive questionnaire that measures the frequency and severity of dyspepsia. The Leeds Dyspepsia Questionnaire fulfils these characteristics, but is long and was not designed for self-completion, so a shorter questionnaire was developed (the Short-Form Leeds Dyspepsia Questionnaire).
Aim: To assess the acceptability, interpretability, internal consistency, reliability, validity and responsiveness of the Short-Form Leeds Dyspepsia Questionnaire in primary and secondary care.
Methods: Unselected primary and secondary care patients completed the Short-Form Leeds Dyspepsia Questionnaire. Test-retest reliability was assessed after 2 days. Validity was measured by comparison with general practitioners' diagnosis. Sensitivity analysis and logistic regression were employed to determine the most valid scoring system. Responsiveness was determined before and after treatment for endoscopically proven disease.
Results: The Short-Form Leeds Dyspepsia Questionnaire was administered to 388 primary care and 204 secondary care patients. The Pearson coefficient for test-retest reliability was 0.93. The Short-Form Leeds Dyspepsia Questionnaire had a sensitivity of 77% and a specificity of 75%. A highly significant response to change was observed (P < 0.005).
Conclusions: The Short-Form Leeds Dyspepsia Questionnaire is a reliable, valid and responsive self-completed outcome measure for quantifying the frequency and severity of dyspepsia symptoms, which is shorter and more convenient than the Leeds Dyspepsia Questionnaire.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-2036.2006.03233.x | DOI Listing |
BJGP Open
September 2024
Primary Care Society for Gastroenterology, Oxford, United Kingdom.
Background: Proton pump inhibitors (PPIs) the most frequently prescribed drug class globally, are often overused.
Aim: To assess PPI prescribing practice in England.
Design & Setting: Electronic medical record (EMR) evaluation from 62 primary care GP practices.
Gut
August 2024
Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Roma, Italy
Objective: Disorders of gut-brain interaction may arise after acute gastroenteritis. Data on the influence of pathogen type on the risk of postinfection IBS (PI-IBS), as on postinfection functional dyspepsia (PI-FD), are limited. We conducted a systematic review and meta-analysis to determine prevalence of PI-IBS or PI-FD after acute gastroenteritis.
View Article and Find Full Text PDFGastroenterol Hepatol Bed Bench
January 2024
Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Aim: Our objective was to assess the efficacy and safety of adding alpha-pinene (a herbal terpenoid) to quadruple therapy compared to a placebo in improving symptoms and Helicobacter pylori (H. pylori) eradication rates in Functional dyspepsia (FD) patients.
Background: FD is a prevalent upper gastrointestinal condition, and no definitive pharmacological treatment is available for its management.
Saudi J Gastroenterol
November 2024
Department of Clinical Medicine and Gastroenterology, Institute of Medicine, University of Bergen, Norway.
Background: Gastroesophageal reflux disease (GERD) is a common chronic digestive disease that affects people in different communities at different rates. Because of the absence of a validated Arabic tool to assess GERD symptoms, this study aimed to validate and culturally adapt the GERD questionnaire (GerdQ) tool to Arabic speakers.
Methods: Patients referred for pH testing with symptoms suggestive of GERD were recruited.
J Scleroderma Relat Disord
June 2024
Division of Gastroenterology, Department of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Aim: To study the prevalence of in systemic sclerosis patients and its gastrointestinal manifestations in comparison with -negative systemic sclerosis patients. Systemic sclerosis gastrointestinal outcome post eradication was evaluated.
Method: In total, 70 systemic sclerosis patients and 70 age-, gender- and race-matched healthy controls had their urea breath test done.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!